• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product.

作者信息

Moll Guido, Drzeniek Norman, Kamhieh-Milz Julian, Geissler Sven, Reinke Petra

机构信息

BIH Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Berlin, Germany.

Berlin-Brandenburg School for Regenerative Therapies (BSRT), Charité Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Br J Haematol. 2020 May;189(4):593-596. doi: 10.1111/bjh.16389. Epub 2020 Feb 10.

DOI:10.1111/bjh.16389
PMID:32037526
Abstract
摘要

相似文献

1
Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product.编辑评论：影响外周血中间充质基质细胞存在的变量及其与单采血液成分的关系。
Br J Haematol. 2020 May;189(4):593-596. doi: 10.1111/bjh.16389. Epub 2020 Feb 10.
2
Flashback 1997: collection of hematopoietic progenitor cells by peripheral blood apheresis after stimulation with granulocyte-colony-stimulating factor.回溯到1997年：在粒细胞集落刺激因子刺激后通过外周血单采术采集造血祖细胞。
Transfusion. 2017 Dec;57(12):3067-3068. doi: 10.1111/trf.14332. Epub 2017 Sep 18.
3
Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation.在儿童中，使用粒细胞集落刺激因子动员外周血干细胞进行移植时，一天内进行两次外周血干细胞单采。
Pediatr Transplant. 2009 Jun;13(4):440-3. doi: 10.1111/j.1399-3046.2008.01037.x. Epub 2008 Oct 7.
4
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.采用粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子联合动员正常供者造血祖细胞可减少移植物中的浆细胞样树突状细胞，并增强供者 T 细胞植入和 Th1 极化：一项随机临床试验的结果。
Biol Blood Marrow Transplant. 2013 Mar;19(3):460-7. doi: 10.1016/j.bbmt.2012.11.017. Epub 2012 Nov 28.
5
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.不同化疗方案联合粒细胞集落刺激因子动员外周血祖细胞治疗的患者单采产物中粒细胞/巨噬细胞集落形成单位与CD34+细胞的相关性
J Cancer Res Clin Oncol. 1998;124(6):341-5. doi: 10.1007/s004320050180.
6
Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency.健康供体中重复外周血干细胞动员：动员效率的时间依赖性变化
Br J Haematol. 1999 Jul;106(1):152-8. doi: 10.1046/j.1365-2141.1999.01518.x.
7
Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis.在通过单采术采集外周血干细胞过程中，CD34+细胞向外周循环的迁移。
Bone Marrow Transplant. 2001 Oct;28(7):649-56. doi: 10.1038/sj.bmt.1703217.
8
Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatment.外周血和造血祖细胞-单采产品中 CD34+ 细胞结果不一致：对临床决策的影响及其对患者治疗的影响。
Transfusion. 2014 Mar;54(3):541-4. doi: 10.1111/trf.12324. Epub 2013 Jun 30.
9
Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant.环磷酰胺和 G-CSF 动员多发性硬化症患者自体移植后 CD34+造血干细胞的动力学。
Cytotherapy. 2020 Mar;22(3):144-148. doi: 10.1016/j.jcyt.2020.01.002. Epub 2020 Feb 10.
10
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.使用改良的目标值定制方法改善外周血造血祖细胞采集前CD34+细胞产量的预测
Biol Blood Marrow Transplant. 2016 Apr;22(4):763-767. doi: 10.1016/j.bbmt.2015.11.016. Epub 2015 Nov 28.

引用本文的文献

1
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products.改良 MSC 最小标准以最大化患者安全：呼吁采用组织因子和 MSC 产品血液相容性评估。
Stem Cells Transl Med. 2022 Mar 3;11(1):2-13. doi: 10.1093/stcltm/szab005.
2
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.间充质基质细胞用于增强造血植入及治疗移植物抗宿主病、出血和急性呼吸窘迫综合征。
Front Immunol. 2022 Mar 18;13:839844. doi: 10.3389/fimmu.2022.839844. eCollection 2022.
3
Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells.
生物指令性水凝胶可扩大间充质干细胞的旁分泌效力。
Biofabrication. 2021 Jul 8;13(4). doi: 10.1088/1758-5090/ac0a32.
4
Intrinsic Angiogenic Potential and Migration Capacity of Human Mesenchymal Stromal Cells Derived from Menstrual Blood and Bone Marrow.源自人月经血和骨髓的间充质基质细胞的内在血管生成潜力和迁移能力。
Int J Mol Sci. 2020 Dec 15;21(24):9563. doi: 10.3390/ijms21249563.
5
The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration : A Review.外周血源性干细胞在软骨修复与再生中的应用：综述
Front Pharmacol. 2020 Apr 3;11:404. doi: 10.3389/fphar.2020.00404. eCollection 2020.